Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ProCort1: Low Dose Prednisolone for HIV
NCT01299948Phase 2Completed
- Sponsor
- Medical Mission Institute Würzburg
- Start
- Jun 2007
- Primary completion
- Mar 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Time to progression of HIV disease at 2 years. Started Jun 2007; status: completed.
02
Drugs
prednisolone
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01299948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299948.